vimarsana.com
Home
Live Updates
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2023 Earnings Call Transcript : vimarsana.com
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2023 Earnings Call Transcript
Operator: Hello. Thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2023 Conference Call. After the speaker's presentation, there will be a question-and-answer session.
Related Keywords
United States ,
France ,
Canada ,
Australia ,
New York ,
French ,
America ,
American ,
John Newman ,
William Pickering ,
Dave Chang ,
Zachary Roberts ,
Michael Schmidt ,
Eric Schmidt ,
Tony Butler ,
Kishore Gangangari ,
Kalpit Patel ,
Tyler Van Baron ,
Ben Burnett ,
William Blair ,
Asthika Goonewardene ,
Salveen Richter ,
Reni Benjamin ,
Kelsey Goodwin ,
Jack Allen ,
Ibanez Ventoso ,
Michael Yee ,
Sami Corwin ,
Brian Cheng ,
Akash Singh ,
Christine Cassiano ,
Jason Gerberry ,
David Chang ,
Goldman Sachs ,
European Hematology Association Congress ,
Nasdaq ,
American Society Of Clinical Oncology ,
American Society Of Clinical Oncology Annual Meeting ,
European Hematology Association ,
International Conference On Malignant Lymphoma In Lugano ,
Allogene Therapeutics Inc ,
Development Agreement ,
Communications Officer ,
National Cancer Institute ,
Allogene Therapeutics ,
Call Transcript August ,
Allogene Therapeutics Second Quarter ,
Chief Communications ,
Chief Executive Officer ,
Executive Vice President ,
Chief Medical Officer ,
Chief Financial ,
American Society ,
Clinical Oncology ,
Cooperative Research ,
Doesnt Repeat ,
Clinical Oncology Annual Meeting ,
International Conference ,
Malignant Lymphoma ,
Ivan Baron ,
Unidentified Analyst ,
North America ,
Luca Issi ,
Carolina Ibanez Ventoso ,
vimarsana.com © 2020. All Rights Reserved.